| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Open Orphan renews contract with Carna Biosciences
StockMarketWire.com
|
Pharmaceutical services group Open Orphan said it had secured a contract renewal with Carna Biosciences.
Carna Biosciences was a clinical-stage biopharmaceutical company focused on development of innovative therapies to treat serious unmet medical needs, focusing on small molecule drugs.
The renewal of the contract is expected to deliver 'significant revenue' to Open Orphan's Venn division over the next twelve months, the company said.
Story provided by StockMarketWire.com
|
|
|
|
|
|
